Image: Dr. Nadja Zeltner is launching NeelaCell Therapeutics to advance her lab’s genipin research into potential treatments for peripheral neuropathy. The company aims to move genipin toward clinical trials, investigate its effects in disease models, and develop innovative cell-based approaches for broader medical applications. Read the full article here Type of News/Audience: Alumni Graduate students Undergraduate students Faculty Staff
